Sigilon Therapeutics, Inc.
COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE

Abstract:

Described herein are RPE cells engineered to secrete a GLA protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating Fabry disease.